Innate Pharma SA Share Price Today: Live Updates & Key Insights
Innate Pharma SA share price today is $1.1736, up -7.87%. The stock opened at $1.3 against the previous close of $1.27, with an intraday high of $1.3 and low of $1.17.
Innate Pharma SA Share Price Chart
Innate Pharma SA
Innate Pharma SA Share Price Performance
Innate Pharma SA Institutional Holdings
Innate Pharma SA Market Status
Innate Pharma SA Fundamentals
Market Cap 110.60 M
PB Ratio 20.0588
PE Ratio 0.0
Enterprise Value 86.19 M
Total Assets 111.06 M
Volume 44972
Innate Pharma SA Company Financials
About Innate Pharma SA & investment objective
Company Information Innate Pharma S.A. operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; IPH5201, a blocking antibody that is in Phase II clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; IPH6401, an BCMA-targeting NK cell engager; and IPH6101, a NKp46-based NK cell engager that targets CD123 proprietary multi-specific antibody format; and IPH62, an B7-H3-targeting NK cell engager. Its products in preclinical trials are IPH43, an anti-MICA/B ADC and IPH45, an antibody drug conjugates (ADC); and IPH67, an undisclosed, multi-specific ANKET. The company has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. Innate Pharma S.A. was incorporated in 1999 and is based in Marseille, France.
Organisation Biotechnology
Employees 174
Industry Biotechnology
CEO Mr. Jonathan E. Dickinson B.Sc., M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Innate Pharma SA FAQs
What is the share price of Innate Pharma SA today?
The current share price of Innate Pharma SA is $1.1736.
Can I buy Innate Pharma SA shares in India?
Yes, Indian investors can buy Innate Pharma SA shares by opening an international trading and demat account with Motilal Oswal.
How to buy Innate Pharma SA shares in India?
You can easily invest in Innate Pharma SA shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Innate Pharma SA shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Innate Pharma SA.
Can I buy fractional shares of Innate Pharma SA?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Innate Pharma SA?
Innate Pharma SA has a market cap of $110.60 M.
In which sector does Innate Pharma SA belong?
Innate Pharma SA operates in the Biotechnology sector.
What documents are required to invest in Innate Pharma SA stocks?
To invest, you typically need:
What is the PE and PB ratio of Innate Pharma SA?
The PE ratio of Innate Pharma SA is N/A and the PB ratio is 20.06.